Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Kimble

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Alcoholism, Clinical and Experimental Research|May 1, 1997
Alcohol, cytokines, and estrogen in the control of bone remodelingR B Kimble
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1997
The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized miceR B Kimble, S Bain, R Pacifici
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapyR Pacifici, J L Vannice, L Rifas, et al.
Calcified Tissue International|October 1, 1994
Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone lossR B Kimble, R Kitazawa, J L Vannice, et al.
The Journal of Biological Chemistry|November 15, 1996
Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor productionR B Kimble, S Srivastava, F P Ross, et al.
The Journal of Clinical Investigation|December 1, 1994
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized miceR Kitazawa, R B Kimble, J L Vannice, et al.
Endocrinology|July 1, 1995
Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy periodR B Kimble, A B Matayoshi, J L Vannice, et al.
Endocrinology|April 17, 2003
Skeletal overexpression of noggin results in osteopenia and reduced bone formationR D Devlin, Z Du, R C Pereira, et al.
Nature Genetics|March 4, 2000
Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate developmentT M DeChiara, R B Kimble, W T Poueymirou, et al.
The Journal of Clinical Investigation|November 20, 1998
Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1S Srivastava, M N Weitzmann, R B Kimble, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Alcoholism, Clinical and Experimental Research|May 1, 1997
Alcohol, cytokines, and estrogen in the control of bone remodelingR B Kimble
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 1, 1997
The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized miceR B Kimble, S Bain, R Pacifici
The Journal of Clinical Endocrinology and Metabolism|November 1, 1993
Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapyR Pacifici, J L Vannice, L Rifas, et al.
Calcified Tissue International|October 1, 1994
Persistent bone-sparing effect of interleukin-1 receptor antagonist: a hypothesis on the role of IL-1 in ovariectomy-induced bone lossR B Kimble, R Kitazawa, J L Vannice, et al.
The Journal of Biological Chemistry|November 15, 1996
Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor productionR B Kimble, S Srivastava, F P Ross, et al.
The Journal of Clinical Investigation|December 1, 1994
Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized miceR Kitazawa, R B Kimble, J L Vannice, et al.
Endocrinology|July 1, 1995
Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy periodR B Kimble, A B Matayoshi, J L Vannice, et al.
Endocrinology|April 17, 2003
Skeletal overexpression of noggin results in osteopenia and reduced bone formationR D Devlin, Z Du, R C Pereira, et al.
Nature Genetics|March 4, 2000
Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate developmentT M DeChiara, R B Kimble, W T Poueymirou, et al.
The Journal of Clinical Investigation|November 20, 1998
Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1S Srivastava, M N Weitzmann, R B Kimble, et al.
Pageof 2